Literature DB >> 18163227

Treatment of eczema.

Christopher Chang1, Carl L Keen, M Eric Gershwin.   

Abstract

Eczema is a chronic inflammatory skin disease that has reached nearly epidemic proportions in childhood. Moreover, it is a difficult disease to control and, with its onset in childhood, is often the first manifestation of atopy. The clinical features of eczema include itchy red skin accompanied by dryness and lichenification. In the past, treatment options consisted primarily of avoidance of soap and water. These options have considerably improved with both nonpharmacologic and pharmacologic approaches. However, eczema is still a treatment challenge. Part of the problem in developing new treatment options has been the relative failure in translating basic science information into clinical application. It is hoped that the newer biologics will help bridge this gap and lead to greater success rates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163227     DOI: 10.1007/s12016-007-0033-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   10.817


  142 in total

1.  Why do patients with atopic dermatitis refuse to apply topical corticosteroids?

Authors:  M Fukaya
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 2.  Itch and atopic dermatitis: an overview.

Authors:  C F Wahlgren
Journal:  J Dermatol       Date:  1999-11       Impact factor: 4.005

3.  Failure of oral zinc supplementation in atopic eczema.

Authors:  C I Ewing; A C Gibbs; C Ashcroft; T J David
Journal:  Eur J Clin Nutr       Date:  1991-10       Impact factor: 4.016

4.  Randomised controlled trial of advice on an egg exclusion diet in young children with atopic eczema and sensitivity to eggs.

Authors:  R Lever; C MacDonald; P Waugh; T Aitchison
Journal:  Pediatr Allergy Immunol       Date:  1998-02       Impact factor: 6.377

5.  Severity scoring of atopic dermatitis: a comparison of three scoring systems.

Authors:  A B Sprikkelman; R A Tupker; H Burgerhof; J P Schouten; P L Brand; H S Heymans; W M van Aalderen
Journal:  Allergy       Date:  1997-09       Impact factor: 13.146

6.  Audit of outcome in 455 consecutive patients treated with homeopathic medicines.

Authors:  R Sevar
Journal:  Homeopathy       Date:  2005-10       Impact factor: 1.444

7.  Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial.

Authors:  A Takwale; E Tan; S Agarwal; G Barclay; I Ahmed; K Hotchkiss; J R Thompson; T Chapman; J Berth-Jones
Journal:  BMJ       Date:  2003-12-13

8.  Allergen-antibody complexes in the treatment of atopic dermatitis: preliminary results of a double-blind placebo-controlled study.

Authors:  B P Leroy; G Boden; M G Jacquemin; J M Lachapelle; J M Saint-Remy
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1992

9.  [Use of alternative medicine in the treatment of allergic diseases].

Authors:  José Alfredo Félix Berumen; Sandra Nora González Díaz; Carlos Canseco González; Alfredo Arias Cruz
Journal:  Rev Alerg Mex       Date:  2004 Mar-Apr

10.  Pyridoxine in atopic dermatitis.

Authors:  D C Mabin; S Hollis; J Lockwood; T J David
Journal:  Br J Dermatol       Date:  1995-11       Impact factor: 9.302

View more
  2 in total

1.  Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children.

Authors:  Hsiewe Ying Tan; Anthony L Zhang; Charlie C Xue; Dacan Chen; Cliff Da Costa; George B Lenon
Journal:  BMJ Open       Date:  2013-12-30       Impact factor: 2.692

2.  Enhanced Expression of IL-18 and IL-18BP in Plasma of Patients with Eczema: Altered Expression of IL-18BP and IL-18 Receptor on Mast Cells.

Authors:  Yalin Hu; Junling Wang; Huiyun Zhang; Hua Xie; Weiwei Song; Qijun Jiang; Nan Zhao; Shaoheng He
Journal:  Mediators Inflamm       Date:  2017-08-03       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.